Browse by People

Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 9.

Sharman, Jeff P, Coutre, Steven E, Furman, Richard R, Cheson, Bruce D, Pagel, John M, Hillmen, Peter, Barrientos, Jacqueline C, Zelenetz, Andrew D, Kipps, Thomas J, Flinn, Ian W
et al (show 14 more authors) (2019) Final Results of a Randomized, Phase III Study of Rituximab With or Without Idelalisib Followed by Open-Label Idelalisib in Patients With Relapsed Chronic Lymphocytic Leukemia. Journal of Clinical Oncology, 37 (16). 1391 - 1402.

Rose-Zerilli, Matthew John Jerome, Parker, Helen, Larrayoz, Marta, Clifford, Ruth, Blakemore, Stuart, Edelmann, Jennifer, Gibson, Jane, Wang, Jun, Ljungstrom, Viktor, Chaplin, Tracy
et al (show 26 more authors) (2015) Genomic Disruption of the Histone Methyltransferase SETD2 in Chronic Lymphocytic Leukemia. .

Schuh, Anna H, Parry-Jones, Nilima, Appleby, Niamh, Bloor, Adrian, Dearden, Claire E, Fegan, Christopher, Follows, George, Fox, Christopher P, Iyengar, Sunil, Kennedy, Ben
et al (show 7 more authors) (2018) Guideline for the treatment of chronic lymphocytic leukaemia: A British Society for Haematology Guideline. BRITISH JOURNAL OF HAEMATOLOGY, 182 (3). 344 - 359.

Hillmen, Peter, Rawstron, Andy C, Brock, Kristian, Munoz-Vicente, Samuel, Yates, Francesca J, Bishop, Rebecca, Boucher, Rebecca, MacDonald, Donald, Fegan, Christopher, McCaig, Alison
et al (show 9 more authors) (2019) Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study. JOURNAL OF CLINICAL ONCOLOGY, 37 (30). 2722 - +.

Pettitt, Andrew R, Jackson, Richard, Cicconi, Silvia, Polydoros, Fotis, Yap, Christina, Dodd, James, Bickerstaff, Matthew, Stackpoole, Michael, Khan, Umair T, Carruthers, Stacey
et al (show 16 more authors) (2020) Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukaemia: final results of the NCRI CLL210 trial. Haematologica.

Eagle, Gina, Zhuang, Jack ORCID: 0000-0003-3245-0789, Oates, Melanie, Kitteringham, Neil, Herbert, John, Falciani, Francesco, Pettitt, Andrew, Park, Kevin, Jenkins, Rosalind, Devereux, Stephen
et al (show 2 more authors) (2017) Linking genotype to clinical phenotype through proteomic analysis of CLL trial samples. .

Kreuzer, Karl-Anton, Furman, Richard R, Stilgenbauer, Stephan, Dubowy, Ronald L, Kim, Yeonhee, Munugalavadla, Veerendra, Lilienweiss, Esther, Reinhardt, Hans Christian, Cramer, Paula, Eichhorst, Barbara
et al (show 4 more authors) (2020) The impact of complex karyotype on the overall survival of patients with relapsed chronic lymphocytic leukemia treated with idelalisib plus rituximab. LEUKEMIA, 34 (1). 296 - 300.

Alharthi, Afaf, Beck, Daniel, Howard, Dena R, Hillmen, Peter, Oates, Melanie, Pettitt, Andrew and Wagner, Simon D ORCID: 0000-0002-8914-0370
(2018) An increased fraction of circulating miR-363 and miR-16 is particle bound in patients with chronic lymphocytic leukaemia as compared to normal subjects. BMC research notes, 11 (1). 280 - ?.

Pratt, Guy, Yap, Christina, Oldreive, Ceri, Slade, Daniel, Bishop, Rebecca, Griffiths, Mike, Dyer, Martin JS, Fegan, Chris, Oscier, David, Pettitt, Andrew
et al (show 9 more authors) (2018) A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma. BRITISH JOURNAL OF HAEMATOLOGY, 182 (3). 429 - 433.

This list was generated on Sun May 10 14:35:37 2020 BST.